Mоlimо vаs kоristitе оvај idеntifikаtоr zа citirаnjе ili оvај link dо оvе stаvkе:
https://open.uns.ac.rs/handle/123456789/8727
Nаziv: | Serum-based DNA methylation biomarkers in colorectal cancer: Potential for screening and early detection | Аutоri: | Summers T. Langan R. Nissan A. Brücher B. Bilchik A. Mlađan Protić Daumer M. Avital I. Stojadinović, Alexander |
Ključnе rеči: | Biomarker;Early detection;Colorectal cancer;DNA methylation;Screening;Serum | Dаtum izdаvаnjа: | 30-авг-2013 | Čаsоpis: | Journal of Cancer | Sažetak: | Colorectal cancer (CRC) is the third most common cause of cancer-related death in the United States. Early identification and treatment of pre-cancerous colorectal lesions, or node-negative CRC are highly effective interventions that substantially reduce disease-specific mortality. Colonoscopy remains a highly effective primary screening tool based on its excellent diagnostic accuracy, and its ability to remove pre-cancerous lesions. However, the nature of the procedure limits compliance with colonoscopy intended for population-based CRC screening. A significant advance in the screening and care of these patients could be realized by blood-based biomarkers, which could accurately identify patients at-risk for CRC development whom might benefit from early and/or more frequent surveillance for disease. We reviewed and herein discuss the potential for serum based DNA methylation biomarkers for screening and early detection of CRC. ©Ivyspring International Publisher. | URI: | https://open.uns.ac.rs/handle/123456789/8727 | DOI: | 10.7150/jca.5839 |
Nаlаzi sе u kоlеkciјаmа: | MDF Publikacije/Publications |
Prikаzаti cеlоkupаn zаpis stаvki
SCOPUSTM
Nаvоđеnjа
43
prоvеrеnо 09.09.2023.
Prеglеd/i stаnicа
32
Prоtеklа nеdеljа
9
9
Prоtеkli mеsеc
0
0
prоvеrеnо 10.05.2024.
Google ScholarTM
Prоvеritе
Аlt mеtrikа
Stаvkе nа DSpace-u su zаštićеnе аutоrskim prаvimа, sа svim prаvimа zаdržаnim, оsim аkо nije drugačije naznačeno.